TY  - GEN
AU  - Soerensen,Anne V
AU  - Donskov,Frede
AU  - Kjellberg,Jakob
AU  - Ibsen,Rikke
AU  - Hermann,Gregers G
AU  - Jensen,Niels V
AU  - Fode,Kirsten
AU  - Geertsen,Poul F
TI  - Health economic changes as a result of implementation of targeted therapy for metastatic renal cell carcinoma: national results from DARENCA study 2
SN  - 1873-7560
PY  - 2016///0606
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Ambulatory Care
KW  - economics
KW  - Angiogenesis Inhibitors
KW  - Antineoplastic Agents
KW  - Bevacizumab
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Costs and Cost Analysis
KW  - Denmark
KW  - Drug Costs
KW  - Efficiency
KW  - Employment
KW  - Everolimus
KW  - Female
KW  - Fluorouracil
KW  - Health Care Costs
KW  - Hospitalization
KW  - Humans
KW  - Immunologic Factors
KW  - Indoles
KW  - Interferon-alpha
KW  - Interleukin-2
KW  - Kidney Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Phenylurea Compounds
KW  - Protein Kinase Inhibitors
KW  - Pyrroles
KW  - Radiography
KW  - Radiotherapy
KW  - Registries
KW  - Sirolimus
KW  - Sorafenib
KW  - Sunitinib
N1  - Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.eururo.2014.12.017
ER  -